List of works - Matthew G. Cottingham

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques

scientific article

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity

scientific article (publication date: 2012)

Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum

scientific article published on 11 June 2015

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates

scientific article published on 3 July 2015

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA).

scientific article

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice

scientific article

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain

scientific article

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

scientific article

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA

scientific article (publication date: 2012)

Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry

scientific article

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates

scientific article (publication date: 2012)

Genetic Manipulation of Poxviruses Using Bacterial Artificial Chromosome Recombineering ⬇️

scientific article published on January 1, 2012

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice

scientific article

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass

scientific article published in February 2010

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity

scientific article published on 21 February 2012

Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination

scientific article published on 4 March 2016

Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.

scientific article

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection

scientific article

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors

scientific article

Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome

scientific article published on 24 April 2010

Recombinant MVA vaccines: dispelling the myths

scientific article published on 21 March 2013

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

scientific article

T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein

scientific article

T cells induced by recombinant chimpanzee adenovirus alone and in prime‐boost regimens decrease chimeric EcoHIV/NDK challenge virus load ⬇️

scientific article published on October 16, 2012

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species

scientific article

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1

scientific article (publication date: 2011)

Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects ⬇️

scientific article published on 05 June 2013

Viral vectors as vaccine platforms: deployment in sight

scientific article published on 20 April 2011

List of works by Matthew G. Cottingham

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity

Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA).

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA

Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates

Genetic Manipulation of Poxviruses Using Bacterial Artificial Chromosome Recombineering ⬇️

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity

Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination

Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors

Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome

Recombinant MVA vaccines: dispelling the myths

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein

T cells induced by recombinant chimpanzee adenovirus alone and in prime‐boost regimens decrease chimeric EcoHIV/NDK challenge virus load ⬇️

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1

Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects ⬇️

Viral vectors as vaccine platforms: deployment in sight